Redefining treatment delivery with our innovative microneedle technology

Our new website is launching soon. For more information, email us or visit our LinkedIn page.

EMAIL US
VISIT OUR LINKEDIN

ABOUT US

Innoture is on a mission to make a meaningful difference to improve patient and public health globally.

We are focused on the design and development of innovative microneedle technology for use with vaccines, medicines, aesthetics, and diagnostic testing.

OUR MICRONEEDLE TECHNOLOGY

At Innoture, we are focussed on enhancing treatments in a range of therapy areas using our microneedle patches to deliver medicines, vaccines and aesthetics through the skin.

We customise the design and manufacture of our microneedles through 3D precision printing by altering their height, width, materials and sharpness. Our microneedles are small, painless and work by perforating the thin outer layer of the skin allowing the medicine or vaccine to enter the body.

HOW WE CAN HELP

PATIENTS

We aim to improve efficacy of treatments and enhance patient experience via our painless and minimally invasive skin patch. We want to enable people to self-care.

HEALTHCARE PROFESSIONALS

Enabling self-administration at home could help HCPs to focus on the patients who need most urgent attention and reduce concerns about needlestick injuries.

 

IMPROVE GLOBAL HEALTH

Increase access to medicines, improve sustainability, simplify and improve supply chains and more effectively deliver vaccines during a global pandemic.

 

THE PHARMACEUTICAL INDUSTRY

Provide the next-generation of treatments, via our rapid and adaptable platform technology that can be used across a range of therapy areas.

 

COVID-19 RESPONSE

We are currently testing our technology for use with a COVID-19 vaccine. We want to overcome the challenges associated with current vaccination programmes to enable self-administration at home, overcome cold-chain storage issues and reduce vaccine wastage.

 

OUR RESEARCH

We are currently undertaking research into the potential use of our innovative microneedle technology for use with COVID-19 and other vaccines.

Our core work is developing the technology focussed on vaccines, pain relief, dermatology, aesthetics and diagnostics.

We are able to rapidly upscale production of our microneedle technology, whilst ensuring exceptional quality standards are met.

WHY PARTNER WITH US?

With a passion to drive innovation forward, at Innoture, we believe our microneedle platform technology will redefine the future delivery of healthcare.

Following a decade of research, and with extensive regulatory experience, we have developed our technology with a mission to enhance patient experience, whilst improving treatment performance, cost-effectiveness and availability. 

We welcome discussions with potential industry, academic and NGO partners as to how we can combine your molecule with our technology to make a meaningful difference to patient and public health. Do get in touch if you would like to join us on this journey.

 

EMAIL US
VISIT OUR LINKEDIN

Innoture Office: 58 Davies Street, London, W1K 5JF

Tel: +44 (0) 8456 804 734

Innoture was awarded funding from the Welsh Government in July 2020 to initiate proof-of-concept research into the use of its next-generation microneedle skin patch for the self-administration of COVID-19 and other vaccines.

 

We continue to be grateful for the support shown by the Welsh Government.